(106)Ruthenium brachytherapy for ciliary recurrence with supraciliary effusion in retinoblastoma

Ophthalmic Genet. 2010 Dec;31(4):190-2. doi: 10.3109/13816810.2010.499888. Epub 2010 Sep 1.

Abstract

Purpose: A 2-year-old boy with syndromic bilateral retinoblastoma resulting from a (del(13)(q12.3q14.3)) developed a recurrent tumor measuring 2.3 X 2.3 mm at the ora serrata 15 months following last treatment.

Methods: Ultrasound biomicroscopy (UBM) revealed a mass invading the ciliary body 6.6 mm in diameter associated with a localized supraciliary effusion.

Results: Complete tumor regression was achieved 1 month after brachytherapy with a (106)Ruthenium plaque. There was no recurrence at 16 months.

Conclusion: This is the first clinical demonstration of supraciliary effusion in recurrent retinoblastoma. Brachytherapy appears to be effective in the treatment of this type of recurrence.

Publication types

  • Case Reports

MeSH terms

  • Brachytherapy*
  • Child, Preschool
  • Chromosome Deletion
  • Chromosomes, Human, Pair 13 / genetics
  • Ciliary Body / diagnostic imaging
  • Ciliary Body / pathology
  • Ciliary Body / radiation effects*
  • Humans
  • Male
  • Microscopy, Acoustic
  • Neoplasm Invasiveness
  • Neoplasm Recurrence, Local / diagnostic imaging
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / radiotherapy*
  • Retinal Neoplasms / diagnostic imaging
  • Retinal Neoplasms / genetics
  • Retinal Neoplasms / radiotherapy*
  • Retinoblastoma / diagnostic imaging
  • Retinoblastoma / genetics
  • Retinoblastoma / radiotherapy*
  • Ruthenium Radioisotopes / therapeutic use*
  • Uveal Neoplasms / diagnostic imaging
  • Uveal Neoplasms / pathology
  • Uveal Neoplasms / radiotherapy*

Substances

  • Ruthenium Radioisotopes